Logo image of MSEX

MIDDLESEX WATER CO (MSEX) Stock Fundamental Analysis

NASDAQ:MSEX - Nasdaq - US5966801087 - Common Stock - Currency: USD

54.67  -1.01 (-1.81%)

After market: 54.67 0 (0%)

Fundamental Rating

4

MSEX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 14 industry peers in the Water Utilities industry. MSEX has a medium profitability rating, but doesn't score so well on its financial health evaluation. MSEX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year MSEX was profitable.
In the past year MSEX had a positive cash flow from operations.
In the past 5 years MSEX has always been profitable.
Each year in the past 5 years MSEX had a positive operating cash flow.
MSEX Yearly Net Income VS EBIT VS OCF VS FCFMSEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

MSEX's Return On Assets of 3.37% is fine compared to the rest of the industry. MSEX outperforms 71.43% of its industry peers.
MSEX has a Return On Equity of 9.55%. This is in the better half of the industry: MSEX outperforms 64.29% of its industry peers.
MSEX has a Return On Invested Capital (3.58%) which is comparable to the rest of the industry.
MSEX had an Average Return On Invested Capital over the past 3 years of 3.15%. This is in line with the industry average of 5.08%.
The 3 year average ROIC (3.15%) for MSEX is below the current ROIC(3.58%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.37%
ROE 9.55%
ROIC 3.58%
ROA(3y)3.33%
ROA(5y)3.5%
ROE(3y)9.27%
ROE(5y)9.73%
ROIC(3y)3.15%
ROIC(5y)3.07%
MSEX Yearly ROA, ROE, ROICMSEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

MSEX's Profit Margin of 22.00% is fine compared to the rest of the industry. MSEX outperforms 64.29% of its industry peers.
In the last couple of years the Profit Margin of MSEX has declined.
MSEX's Operating Margin of 28.06% is in line compared to the rest of the industry. MSEX outperforms 50.00% of its industry peers.
In the last couple of years the Operating Margin of MSEX has remained more or less at the same level.
Industry RankSector Rank
OM 28.06%
PM (TTM) 22%
GM N/A
OM growth 3Y6.13%
OM growth 5Y1.01%
PM growth 3Y-3.22%
PM growth 5Y-1.69%
GM growth 3YN/A
GM growth 5YN/A
MSEX Yearly Profit, Operating, Gross MarginsMSEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

MSEX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
MSEX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MSEX has been increased compared to 5 years ago.
The debt/assets ratio for MSEX has been reduced compared to a year ago.
MSEX Yearly Shares OutstandingMSEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MSEX Yearly Total Debt VS Total AssetsMSEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.19, we must say that MSEX is in the distress zone and has some risk of bankruptcy.
With a decent Altman-Z score value of 1.19, MSEX is doing good in the industry, outperforming 64.29% of the companies in the same industry.
MSEX has a Debt/Equity ratio of 0.85. This is a neutral value indicating MSEX is somewhat dependend on debt financing.
The Debt to Equity ratio of MSEX (0.85) is better than 64.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Altman-Z 1.19
ROIC/WACC0.44
WACC8.08%
MSEX Yearly LT Debt VS Equity VS FCFMSEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

MSEX has a Current Ratio of 0.46. This is a bad value and indicates that MSEX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.46, MSEX is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
MSEX has a Quick Ratio of 0.46. This is a bad value and indicates that MSEX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.39, MSEX is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.46
Quick Ratio 0.39
MSEX Yearly Current Assets VS Current LiabilitesMSEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 19.31% over the past year.
The Earnings Per Share has been growing slightly by 4.31% on average over the past years.
MSEX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.01%.
MSEX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.35% yearly.
EPS 1Y (TTM)19.31%
EPS 3Y6.07%
EPS 5Y4.31%
EPS Q2Q%-10.17%
Revenue 1Y (TTM)16.01%
Revenue growth 3Y10.27%
Revenue growth 5Y7.35%
Sales Q2Q%9.32%

3.2 Future

The Earnings Per Share is expected to grow by 8.46% on average over the next years. This is quite good.
Based on estimates for the next years, MSEX will show a quite strong growth in Revenue. The Revenue will grow by 9.58% on average per year.
EPS Next Y3.45%
EPS Next 2Y5.98%
EPS Next 3Y8.46%
EPS Next 5YN/A
Revenue Next Year10.25%
Revenue Next 2Y9.03%
Revenue Next 3Y9.58%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MSEX Yearly Revenue VS EstimatesMSEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
MSEX Yearly EPS VS EstimatesMSEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 22.68, MSEX is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of MSEX is on the same level as its industry peers.
MSEX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.30.
With a Price/Forward Earnings ratio of 19.71, MSEX is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MSEX is on the same level as its industry peers.
MSEX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.76.
Industry RankSector Rank
PE 22.68
Fwd PE 19.71
MSEX Price Earnings VS Forward Price EarningsMSEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MSEX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.95
MSEX Per share dataMSEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MSEX does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)6.58
PEG (5Y)5.26
EPS Next 2Y5.98%
EPS Next 3Y8.46%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.26%, MSEX has a reasonable but not impressive dividend return.
MSEX's Dividend Yield is slightly below the industry average, which is at 3.34.
Compared to an average S&P500 Dividend Yield of 2.37, MSEX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.26%

5.2 History

On average, the dividend of MSEX grows each year by 6.43%, which is quite nice.
MSEX has been paying a dividend for at least 10 years, so it has a reliable track record.
MSEX has decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.43%
Div Incr Years2
Div Non Decr Years2
MSEX Yearly Dividends per shareMSEX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

MSEX pays out 55.41% of its income as dividend. This is a bit on the high side, but may be sustainable.
MSEX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP55.41%
EPS Next 2Y5.98%
EPS Next 3Y8.46%
MSEX Yearly Income VS Free CF VS DividendMSEX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M
MSEX Dividend Payout.MSEX Dividend Payout, showing the Payout Ratio.MSEX Dividend Payout.PayoutRetained Earnings

MIDDLESEX WATER CO

NASDAQ:MSEX (7/11/2025, 8:00:02 PM)

After market: 54.67 0 (0%)

54.67

-1.01 (-1.81%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryWater Utilities
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-31 2025-07-31/amc
Inst Owners78.94%
Inst Owner Change0%
Ins Owners0.97%
Ins Owner Change8.13%
Market Cap979.69M
Analysts82.22
Price Target67.66 (23.76%)
Short Float %2.59%
Short Ratio3.81
Dividend
Industry RankSector Rank
Dividend Yield 1.26%
Yearly Dividend1.32
Dividend Growth(5Y)6.43%
DP55.41%
Div Incr Years2
Div Non Decr Years2
Ex-Date05-15 2025-05-15 (0.34)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.39%
Min EPS beat(2)-8.84%
Max EPS beat(2)31.61%
EPS beat(4)2
Avg EPS beat(4)7.12%
Min EPS beat(4)-9.62%
Max EPS beat(4)31.61%
EPS beat(8)3
Avg EPS beat(8)-4.23%
EPS beat(12)3
Avg EPS beat(12)-11.1%
EPS beat(16)5
Avg EPS beat(16)-8.97%
Revenue beat(2)1
Avg Revenue beat(2)3.29%
Min Revenue beat(2)-0.82%
Max Revenue beat(2)7.4%
Revenue beat(4)2
Avg Revenue beat(4)1.8%
Min Revenue beat(4)-2.46%
Max Revenue beat(4)7.4%
Revenue beat(8)2
Avg Revenue beat(8)-4.54%
Revenue beat(12)2
Avg Revenue beat(12)-5.02%
Revenue beat(16)2
Avg Revenue beat(16)-4.61%
PT rev (1m)0%
PT rev (3m)6.42%
EPS NQ rev (1m)-0.74%
EPS NQ rev (3m)-0.74%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.57%
Revenue NQ rev (1m)-2.39%
Revenue NQ rev (3m)-2.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.94%
Valuation
Industry RankSector Rank
PE 22.68
Fwd PE 19.71
P/S 5.01
P/FCF N/A
P/OCF 14.88
P/B 2.17
P/tB 2.17
EV/EBITDA 15.95
EPS(TTM)2.41
EY4.41%
EPS(NY)2.77
Fwd EY5.07%
FCF(TTM)-0.74
FCFYN/A
OCF(TTM)3.68
OCFY6.72%
SpS10.92
BVpS25.15
TBVpS25.15
PEG (NY)6.58
PEG (5Y)5.26
Profitability
Industry RankSector Rank
ROA 3.37%
ROE 9.55%
ROCE 4.66%
ROIC 3.58%
ROICexc 3.59%
ROICexgc 3.59%
OM 28.06%
PM (TTM) 22%
GM N/A
FCFM N/A
ROA(3y)3.33%
ROA(5y)3.5%
ROE(3y)9.27%
ROE(5y)9.73%
ROIC(3y)3.15%
ROIC(5y)3.07%
ROICexc(3y)3.16%
ROICexc(5y)3.08%
ROICexgc(3y)3.16%
ROICexgc(5y)3.08%
ROCE(3y)4.13%
ROCE(5y)3.98%
ROICexcg growth 3Y9.39%
ROICexcg growth 5Y1.66%
ROICexc growth 3Y9.39%
ROICexc growth 5Y1.66%
OM growth 3Y6.13%
OM growth 5Y1.01%
PM growth 3Y-3.22%
PM growth 5Y-1.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Debt/EBITDA 4.54
Cap/Depr 264.06%
Cap/Sales 40.45%
Interest Coverage 3.95
Cash Conversion 77.6%
Profit Quality N/A
Current Ratio 0.46
Quick Ratio 0.39
Altman-Z 1.19
F-Score7
WACC8.08%
ROIC/WACC0.44
Cap/Depr(3y)301.61%
Cap/Depr(5y)341.57%
Cap/Sales(3y)49.79%
Cap/Sales(5y)55.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.31%
EPS 3Y6.07%
EPS 5Y4.31%
EPS Q2Q%-10.17%
EPS Next Y3.45%
EPS Next 2Y5.98%
EPS Next 3Y8.46%
EPS Next 5YN/A
Revenue 1Y (TTM)16.01%
Revenue growth 3Y10.27%
Revenue growth 5Y7.35%
Sales Q2Q%9.32%
Revenue Next Year10.25%
Revenue Next 2Y9.03%
Revenue Next 3Y9.58%
Revenue Next 5YN/A
EBIT growth 1Y31.98%
EBIT growth 3Y17.03%
EBIT growth 5Y8.43%
EBIT Next Year65.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.96%
OCF growth 3Y21.15%
OCF growth 5Y10.25%